Digital Health in the Management of Pediatric Growth Hormone Therapy – 10 Years of Developments

Growth hormone administration is approved for use in a number of growth failure conditions children. Optimal outcome requires continuous daily injections over many years, leading to problems persistence and adherence with therapy. The easypod™ connect ecosystem enables electronic monitoring injection dose history, transmitted secure cloud database via the internet or cellular networks. Thus, healthcare providers can easily monitor therapy be alerted problems. growlink™ patient app has been added provide solutions that engage educate patients their families/caregivers. also allows self-report height weight, enabling track progression. support program, TuiTek Augmented Reality (AR) are being developed within telehealth services, increase disease awareness reduce therapy-related anxiety. provides objective assessments adherence, shown maintained at high level several analyses showed increased was significantly associated better outcome. Studies have identified factors influence GH ecosystem. These novel technologies generating enable data-driven personalized care children disorders optimize long-term clinical outcomes.